New development of monoclonal antibodies targeting TRAIL agonist receptors

被引：0
|
作者：
Dubuisson, Agathe [1 ]
机构：
[1] Lipide, Nutr, Canc, Dijon, France
来源：
CANCER IMMUNOLOGY RESEARCH | 2019年 / 7卷 / 02期
关键词：
D O I：
10.1158/2326-6074.CRICIMTEATIAACR18-B009
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B009
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Characterization of monoclonal antibodies directed against trail or trail receptors
    Vermot-Desroches, C
    Sergent, E
    Bonnin, B
    Wijdenes, J
    CELLULAR IMMUNOLOGY, 2005, 236 (1-2) : 86 - 91
  • [2] Monoclonal Antibodies Targeting the ErbB Receptors
    Cho, B. C.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S97 - S98
  • [3] Functional analysis of TRAIL receptors using monoclonal antibodies
    Griffith, TS
    Rauch, CT
    Smolak, PJ
    Waugh, JY
    Boiani, N
    Lynch, DH
    Smith, CA
    Goodwin, RG
    Kubin, MZ
    JOURNAL OF IMMUNOLOGY, 1999, 162 (05): : 2597 - 2605
  • [4] Targeting death receptors with agonistic monoclonal antibodies
    Cohen, Roger B.
    CANCER INVESTIGATION, 2007, 25 : 65 - 65
  • [5] Strict targeting of receptors by strereospecific monoclonal antibodies
    Tomita, M.
    Miyamae, C.
    Isozaki, Y.
    Yamasaki, Y.
    Tsumoto, K.
    FEBS JOURNAL, 2014, 281 : 503 - 504
  • [6] Development of monoclonal antibodies to integrin receptors
    Wayner, E. A.
    Hoffstrom, B. G.
    INTEGRINS, 2007, 426 : 117 - 153
  • [7] MONOCLONAL ANTIBODIES AGAINST TRAIL
    Liabakk, Nina-Beate
    Espevik, Terje
    TRAIL (TNF-RELATED APOPTOSIS-INDUCING LIGAND), 2004, 67 : 65 - 79
  • [8] Targeting TRAIL death receptors
    Oldenhuis, C. N. A. M.
    Stegehuis, J. H.
    Walenkamp, A. M. E.
    de Jong, S.
    de Vries, E. G. E.
    CURRENT OPINION IN PHARMACOLOGY, 2008, 8 (04) : 433 - 439
  • [9] Targeting apoptosis: preclinical and early clinical experience with mapatumumab, an agonist monoclonal antibody targeting TRAIL-R1
    Moretto, Patricia
    Hotte, Sebastien J.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2009, 18 (03) : 311 - 325
  • [10] Development and characterization of functional antibodies targeting NMDA receptors
    Nami Tajima
    Noriko Simorowski
    Remy A. Yovanno
    Michael C. Regan
    Kevin Michalski
    Ricardo Gómez
    Albert Y. Lau
    Hiro Furukawa
    Nature Communications, 13
12345